DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $387,220 | -74.9% | 39,472 | -72.8% | 0.01% | -66.7% |
Q4 2022 | $1,542,619 | +35.2% | 144,983 | +32.6% | 0.03% | +42.1% |
Q3 2022 | $1,141,000 | +555.7% | 109,334 | +579.9% | 0.02% | +533.3% |
Q1 2022 | $174,000 | -75.0% | 16,080 | -67.6% | 0.00% | -83.3% |
Q4 2021 | $697,000 | -26.8% | 49,570 | 0.0% | 0.02% | +5.9% |
Q3 2021 | $952,000 | +16.4% | 49,570 | -40.4% | 0.02% | +21.4% |
Q1 2021 | $818,000 | +60.1% | 83,183 | -29.7% | 0.01% | -6.7% |
Q3 2020 | $511,000 | -49.0% | 118,300 | +4.8% | 0.02% | -68.8% |
Q2 2020 | $1,001,000 | – | 112,900 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |